Devin Whittemore Smith

Insider

First SEC filing: Jan. 3, 2020 · Latest: Jan. 3, 2020

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Oct. 13, 2020	NERV	A	85,000	—	—	85,000 Direct	—	Acquired	(price as of 2026-08-20)
June 19, 2020	NERV	A	153,531	—	—	153,531 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 31, 2019	NERV	A	41,469	—	—	41,469 Direct	—	Acquired	(price as of 2026-08-20)
Dec. 11, 2018	NERV	A	120,000	—	—	120,000 Direct	—	Acquired	(price as of 2026-08-20)
Aug. 1, 2018	NERV	A	200,000	—	—	200,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Oct. 13, 2020	NERV	Employee Stock Option (right to buy)	Common Stock (85,000)	$3.50	Oct. 12, 2030	85,000	Acquired
June 19, 2020	NERV	Employee Stock Option (right to buy)	Common Stock (153,531)	$7.11	Dec. 31, 2029	153,531	Acquired
Dec. 31, 2019	NERV	Employee Stock Option (right to buy)	Common Stock (41,469)	$7.11	Dec. 30, 2029	41,469	Acquired
Dec. 11, 2018	NERV	Employee Stock Option (right to buy)	Common Stock (120,000)	$7.96	Dec. 10, 2028	120,000	Acquired
Aug. 1, 2018	NERV	Employee Stock Option (Righ to Buy)	Common Stock (200,000)	$7.95	Aug. 1, 2028	200,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).